Soy isoflavones supplements, which are phyto-oestrogens widely used as alternatives to alleviate menopausal syndromes or prevent chronic diseases, may exert oestrogenic and anti-oestrogenic activities. This study aimed to investigate the effects of soy isoflavones supplement on oestrogen-related autoimmune disease, such as systemic lupus erythematosus, using autoimmune-prone female MRL-lpr/lpr mice. Eighty mice of 8 weeks were divided into five groups: 0 (Control), 2 (Isf 2), 10 (Isf 10) and 20 (Isf 20) mg/kg BW/day Phyto SoyaTM isoflavones or 0.375 mg/kg BW/day tamoxifen (TAM) as the positive control, by tube-feeding. Some mice were killed at age 15 weeks for cellular cytokine secretion. The data suggested that the Isf 20 and TAM groups had higher weight gain and survival compared with the control group. At age 22 weeks, the Isf 20 group still had 75% survival comparable to mice treated with TAM. At age 14 weeks, the TAM group showed significantly lower serum anti-double-stranded (ds) DNA IgG and anti-cardiolipin IgG. The mice in the Isf 10 and Isf 20 groups also had lower anti-dsDNA IgG and anti-cardiolipin IgG. The interferon (IFN)-γ secretion from mitogen-stimulated T cells in the Isf 20 and TAM groups were significantly lower than those of control mice. Furthermore, the oestrogenic activity of the methanol extracts of soy isoflavones for oestrogen receptor (ER)β, but not ERα, significantly increased, suggesting that soy isoflavones have a selective modulation of ER activation. Thus, soy isoflavone supplementation did not aggravate murine lupus, but apparently ameliorated the disease.
1 Lahita RG . The importance of estrogen in systemic lupus erythematosus.Clin Immunol Immunopathol1992; 63: 17–18.
2.
2 Cooper GS Dooley MA Treadwell EL St. Clair EW Parks CG . Hormonal, environmental, and infectious, risk factors for developing systemic lupus erythematosus.Arthritis Rheum1998; 41: 1714–1724.
3.
3 Whitacre CC Reingold SC O’Looney PA . A gender gap in autoimmunity.Science1999; 283: 1277–1278.
4.
4 Garovich M Agudelo C Pisko E . Oral contraceptives and systemic lupus erythematosus.Arthritis Rheum1980; 23: 1396–1398.
5.
5 Holmdahl R . Estrogen exaggerates lupus but suppresses T-cell-dependent autoimmune disease.J Autoimmun1989; 2: 651–656.
6.
6 Carlsten H Tarkowski A Holmdahl R Nilsson LA . Oestrogen is a potent disease accelerator in SLE-prone MRL-lpr/lpr mice.Clin Exp Immunol1990; 80: 467–473.
7.
7 Auborn KJ Qi M Yan XJ . Life span is prolonged in autoimmune-prone (NZB/NZW) F1 mice fed a diet supplemented with indole-3-carbinol.J Nutr2003; 133: 3610–3613.
8.
8 Jordan VC . Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.Br J Pharmacol1993; 110: 507–517.
9.
9 Nayfield SG . Tamoxifen's role in chemoprevention of breast cancer: an update.J Cell Biochem1995; 22(Suppl.): 42–50.
10.
10 Dayan M Zinger H Kalush F . The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations.Immunology1997; 90: 101–108.
11.
11 Wu WM Lin BF Suen JL Chiang BL . Tamoxifen decreases renal inflammation and alleviates disease severity in autoimmune NZB/W F1 mice.Scand J Immunol2000; 52: 393–400.
12.
12 Wu WM Suen JL Lin BF Chiang BL . Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice.Immunology2000; 100: 110–118.
13.
13 Andrews BS Eisenberg RA Theofilopoulos AN . Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.J Exp Med1978; 148: 1198–1215.
14.
14 Cohen PL Eisenberg RA . Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.Annu Rev Immunol1991; 9: 243–269.
15.
15 Pollard KM Pearson DL Hultman P Hildebrandt B Kono DH . Lupus-prone mice as models to study xenobiotic-induce acceleration of systemic autoimmunity.Environ Health Perspect1999; 107(Suppl. 5): 729S–735S.
16.
16 Birt DF Hendrich S Wang W . Dietary agents in cancer prevention: 9 flavonoids and isoflavonoids.Pharmacol Ther2001; 90: 157–177.
17.
17 Tsai M Clark JM Schrader WT O’Malley BW . Mechanism of action of hormones that act as transcription-regulatory factors. In: JD Wilson DW Foster HM Kronenberg PR Larsen , (eds), Williams textbook of endocrinology.Philadelphia, PA: WB Saunders Co.; 1998. p. 55–94.
18.
18 Kao TH Wu WM Hung CF Wu WB Chen BH . Anti-inflammatory effects of isoflavone powder produced from soybean cake.J Agric Food Chem2007; 55: 11068–11079.
19.
19 Velasquez MT Bhathena SJ . Dietary phytoestrogens: a possible role in renal disease protection.Am J Kidney Dis2001; 37: 1056–1068.
20.
20 American Institute of Nutrition. Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies.J Nutr1997; 107: 1340–1348.
21.
21 National Research Council. Guide for the care and use of laboratory animals. Bethesda, MD: National Institutes of Health; 1985. Publication No. 85–23.
22.
22 Lin BF Jeng SJ . Effects of dietary frying oil on lipids and anticardiolipin antibody levels in autoimmune-prone NZB/W F1 mice.Nutr Res1997; 17: 1047.
23.
23 Kuo LC Cheng WY Wu RY Huang CJ Lee KT . Hydrolysis of black soybean isoflavone glycosides by Bacillus subtilis natto.Appl Microbiol Biotechnol2006; 73: 314–320.
24.
24 Chao CY Huang CJ . Bitter gourd (Momordica charantia) extract activates PPAR and up-regulates the expression of acyl CoA oxidase gene in H4IIEC3 hepatoma cells.J Biomed Sci2003; 10: 782–791.
25.
25 Hahn BH . Animal models of systemic lupus erythematosus. In: DJ Wallace BH Hahn , (eds), Dubois' lupus erythematosus.Baltimore: Williams, and Wilkins; 1997. p. 339–356.
26.
26 Jonsson R Tarkowski A Backman K Holmdahl R Klareskog L . Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells.Immunology1987; 60: 611–616.
27.
27 Tarkowski A Jonsson R Sanchez R Klareskog L Koopman WJ . Features of renal vasulitis in autoimmune MRL-lpr/lpr mice: phenotypes and functional properties of infiltrating cells.Clin Exp Immunol1988; 72: 91–97.
28.
28 Loizou S Samarko M Norsworthy PJ Cazabon JK Walport MJ Davies KA . Significance of anticardiolipin and anti-beta 2-glycoprotein I antibodies in lupus nephritis.Rheumatology2000; 39: 962–968.
30 McNeil HP Chesterman CN Krilis SA . Immunology and clinical importance of antiphospholipid antibodies.Adv Immunol1991; 49: 193–280.
31.
31 Ahmed AS Boone J . Anticardiolipin antibodies in autoimmune-prone BXSB and MRL/lpr mice, and estrogen-treated normal C57BL/6J mice cross-react with other phospholipids.Int J Immunopathol Pharmacol1993; 6: 135–147.
32.
32 Hashimoto Y Kawamura M Ichikawa K . Anticardiolipin antibodies in NZW×BXSB F1 mice.J Immunol1992; 149: 1063–1068.
33.
33 Hsieh CC Lin BF . The effects of vitamin E supplementation on autoimmune-prone NZB/W F1 mice fed an oxidized oil diet.Br J Nutr2005; 93: 655–622.
34.
34 Hsieh CC Lin BF . Opposite effects of low and high dose supplementation of vitamin E on survival of MRL-lpr/lpr mice.Nutrition2005; 21: 940–948.
35.
35 Li J McMurray RW . Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model.Clin Immunol2007; 123: 219–226.
36.
36 Kubo C Johnson BC Day NK Good RA . Calorie source, calorie restriction, immunity and aging of NZB/W F1 mice.J Nutr1984; 114: 1884–1899.
37.
37 Urao M Ueda G Abe M Kanno K Hirose S Shirai T . Food restriction inhibits an autoimmune disease resembling systemic lupus erythematosus in (NZBxNZW) F1 mice.J Nutr1995; 125: 2316–2324.
38.
38 Aringer M Smolen JS . Cytokine expression in lupus kidneys.Lupus2005; 14: 13–18.
39.
39 Balomenos D Rumold R Theofilopoulos AN . IFN-γ is required for lupus-like disease and lymphoaccumulation in MRL/lpr mice.J Clin Invest1998; 101: 364–371.
40.
40 Haas C Ryffel B Hir ML . IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB×NZW) F1 mice.J Immunol1998; 160: 3713–3718.
41.
41 Hasegawa K Hayashi T Maeda K . Promotion of lupus in NZB×NZW F1 mice by plasmids encoding interferon (IFN)-γ but not by those encoding interleukin (IL)-4.J Comp Pathol2002; 127: 1–6.
42.
42 Asanuma Y Chung CP Oeser A . Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors.J Rheumatol2006; 33: 539–545.
43.
43 Verdrengh M Jonsson IM Holmdahl R Tarkowski A . Genistein as an anti- inflammatory agent.Inflamm Res2003; 52: 341–346.
44.
44 Hämäläinen M; Nieminen R; Vuorela P; Heinonen M; Moilanen E; . Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007; 2007: 45673.
45.
45 Chacko BK Chandler RT D'Alessandro TL . Anti-inflammatory effects of isoflavones are dependent on flow and human endothelial cell PPARgamma.J Nutr2007; 137: 351–356.
46.
46 Calemine J Zalenka J Karpuzoglu–Sahin E Ward DL Lengi A Ahmed SA . The immune system of geriatric mice is modulated by estrogenic endocrine disruptors (diethylstilbestrol, alpha-zearalanol, and genistein): effects on interferon-gamma.Toxicology2003; 194: 115–128.
47.
47 Rider V Foster RT Evans MJ Suenaga R Abdou NI . Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus.Clin Immunol Immunopathol1998; 89: 171–180.
48.
48 Rider V Jones SR Evans MJ Abdou NI . Molecular mechanism involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells.Clin Immunol2000; 85: 124–134.
49.
49 Sawai C Anderson K Walser–Kuntz D . Effect of bisphenol A on murine function: modulation of interferon-gamma, IgG2a, and disease symptoms in NZB×NZW F1 mice.Environ Health Perspect2003; 111: 1883–1887.
50.
50 Kuiper GG Lemmen JG Carlsson B . Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.Endocrinology1998; 139: 4252–4263.
51.
51 Curran EM Judy BM Newton LG . Dietary soy phytoestrogens and ERalpha signalling modulate interferon gamma production in response to bacterial infection.Clin Exp Immunol2004; 135: 219–225.
52.
52 Lambert KC Curran EM Judy BM Milligan GN Lubahn DB Estes DM . Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation.J Immunol2005; 175: 5716–5723.
53.
53 Imamov O Shim GJ Warner M Gustafsson JA . Estrogen receptor beta in health and disease.Biol Reprod2005; 73: 866–871.
54.
54 Zhao JH Sun SJ Horiguchi H . A soy diet accelerates renal damage in autoimmune MRL/Mp-lpr/lpr mice.Int Immunopharmacol2005; 5: 1601–1610.
55.
55 Setchell KD Brown NM Desai P . Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.J Nutr2001; 131: 1362S–1375S.
